Rachel Tanner

Rachel Tanner

Associate Professor 

Jenner Institute, University of Oxford, UK

Tel: +44 (0)1865 617615

Email: Rachel.Tanner@ndm.ox.ac.uk





Network Management Board member 2018-2021, VALIDATE Fellow 2018-2021, Network Associate


Research Keywords: 

TB, vaccine, immunology, correlates of protection



My research interests are immune correlates and the host immune response to TB vaccination, with a focus on the development of functional mycobacterial growth inhibition assays (MGIAs). In addition, I work on projects studying the role of antibodies in vaccine-induced protection and understanding the variation in vaccine immunogenicity observed in different populations.


Related Websites: 

Profile page at Jenner Institute


Profile page on ResearchGate


Key Publications:

Tanner R, O’Shea MK, White AD, Müller J, Harrington-Kandt R, Matsumiya M, Dennis MJ, Parizotto EA, Harris S, Stylianou E, Naranbhai V, Bettencourt P, Drakesmith H, Sharpe S, Fletcher HA, McShane H. The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays. Sci Rep. 2017 Mar 3;7:43478.

Tanner R, McShane H. Replacing, reducing and refining the use of animals in tuberculosis vaccine research. ALTEX. 2017;34(1):157-166.

Tanner R, O'Shea MK, Fletcher HA, McShane H. In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy. Vaccine. 2016 Aug 12. pii: S0264-410X(16)30656-9.

Fletcher H, Snowden M, Landry B, Rida W, Satti I, Harris S, Matsumiya M, Tanner R, O’Shea M, Dheenadhayalan V, Bogardus L, Stockdale L, Marsay L, Chomka A, Harrington-Kandt R, Manjaly Thomas ZR, Naranbhai V, Stylianou E, Darboe F, Penn Nicholson A, McShane H, et al. T-cell activation is an immune correlate of risk in BCG vaccinated infants. Nature Communications. 2016 April 12. Article number: 11290.

Tanner R, Kakalacheva K, Miller E, Pathan AA, Chalk R, Sander CR, Scriba T, Tameris M, Hawkridge T, Mahomed H, Hussey G, Hanekom W, Checkley A, McShane H, Fletcher HA. Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A. BMC Infect Dis. 2014 Dec 3;14(1):660.

Fletcher HA, Tanner R, Wallis RS, Meyer J, Manjaly ZR, Harris S, Satti I, Silver RF, Hoft D, Kampmann B, Walker KB, Dockrell HM, Fruth U, Barker L, Brennan MJ, McShane H. Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG. Clin Vaccine Immunol. 2013 Nov; 20(11):1683-9.